Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2020 | 3 |
2021 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and Immunosuppression.
Cancer Discov. 2021 Feb;11(2):446-479. doi: 10.1158/2159-8290.CD-20-0775. Epub 2020 Oct 30.
Cancer Discov. 2021.
PMID: 33127842
Free PMC article.
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma.
Makhov P, Sohn JA, Serebriiskii IG, Fazliyeva R, Khazak V, Boumber Y, Uzzo RG, Kolenko VM.
Makhov P, et al.
Br J Cancer. 2020 Dec;123(12):1749-1756. doi: 10.1038/s41416-020-01087-x. Epub 2020 Sep 24.
Br J Cancer. 2020.
PMID: 32968206
Free PMC article.
Item in Clipboard
Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers.
Makhov P, Uzzo RG, Tulin AV, Kolenko VM.
Makhov P, et al.
Urol Oncol. 2021 Jun;39(6):312-315. doi: 10.1016/j.urolonc.2020.04.004. Epub 2020 May 8.
Urol Oncol. 2021.
PMID: 32402770
Free PMC article.
Review.
Item in Clipboard
PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilization.
Zhao Z, Kurimchak A, Nikonova AS, Feiser F, Wasserman JS, Fowle H, Varughese T, Connors M, Johnson K, Makhov P, Lindskog C, Kolenko VM, Golemis EA, Duncan JS, Graña X.
Zhao Z, et al.
Oncogenesis. 2019 Dec 10;8(12):72. doi: 10.1038/s41389-019-0180-9.
Oncogenesis. 2019.
PMID: 31822657
Free PMC article.
Item in Clipboard
Non-NAD-like PARP-1 inhibitors in prostate cancer treatment.
Karpova Y, Wu C, Divan A, McDonnell ME, Hewlett E, Makhov P, Gordon J, Ye M, Reitz AB, Childers WE, Skorski T, Kolenko V, Tulin AV.
Karpova Y, et al.
Biochem Pharmacol. 2019 Sep;167:149-162. doi: 10.1016/j.bcp.2019.03.021. Epub 2019 Mar 15.
Biochem Pharmacol. 2019.
PMID: 30880062
Free PMC article.
Item in Clipboard
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.
Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM.
Makhov P, et al.
Mol Cancer Ther. 2018 Jul;17(7):1355-1364. doi: 10.1158/1535-7163.MCT-17-1299.
Mol Cancer Ther. 2018.
PMID: 29967214
Free PMC article.
Review.
Item in Clipboard
Cite
Cite